Newsfeeds - Spark Newswire

4 minute read

The Daily Biotech Pulse: Adcom Backs Merck’s Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case

By Shanthi Rexaline

Today, 2:53 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADTX

1 minute read

Why Are Immunome Shares Trading Higher Today?

By Vandana Singh

Today, 2:53 AM

Immunome Inc (NASDAQ:IMNM) has submitted an Investigational New Drug (IND) application to the FDA for IMM-BCP-01, a three-antibody…

IMNM

1 minute read

Immunome Announces Submission Of An Investigational New Drug Application For IMM-BCP-01 For The Treatment Of COVID-19

By Benzinga Newsdesk

Today, 2:53 AM

- IMM-BCP-01 targets three non-overlapping regions on the Spike protein to provide broad coverage across CDC current and former variants of concern - IMM-BCP-01 elicits multi-modal activity in pre-clinical testing

IMNM

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 29, 2021

By Benzinga Insights

Today, 2:53 AM

ACVA

5 minute read

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:53 AM

Gainers

ACHR

5 minute read

54 Biggest Movers From Friday

By Lisa Levin

Today, 2:53 AM

Gainers

ADGI

3 minute read

35 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 2:53 AM

Gainers Biomerica, Inc. (NASDAQ: BMRA) shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.

ADGI

1 minute read

Events
News

Immunome To Present Preclinical Data On Anti IL-38 Antibody Program At The American Association For Cancer Research NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics

By Benzinga Newsdesk

Today, 2:53 AM

Immunome, Inc. (NASDAQ:IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today announced that it will be making an oral poster

IMNM